Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ALKS stock hub

Alkermes plc has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ALKSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.8B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ALKS

In the news

Latest news · ALKS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.7

P25 12.3P50 18.4P75 33.1

Trailing P/E38.5

P25 14.9P50 23.2P75 38.5

ROE9.4

P25 -105.6P50 -46.5P75 -3.1

ROIC8.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ALKS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

246

Groups with data

Currency

USD

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001520262
Company name	Alkermes plc
Country	Ireland
Country code	US
Cusip	G01767105
Employees	2,050
Employees Change	250%
Employees Change Percent	13.89
Enterprise value	$6.9B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	1991-07-16
Isin	IE00B56GVS15
Last refreshed	2026-05-10
Market cap	$5.8B
Market cap category	Mid-Cap
Price	$34.99
Price currency	USD
Rev Per Employee	762,097.56x
Sector	Healthcare
Sic	2834
Symbol	ALKS
Website	https://www.alkermes.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.62%
EV Earnings	45.19x
EV Sales Forward	3.64x
EV/EBIT	28.83x
EV/EBITDA	24.77x
EV/FCF	31.12x
EV/Sales	4.42x
FCF yield	3.8%
Forward P/E	20.72x
P/B ratio	3.33x
P/E ratio	38.47x
P/S ratio	3.73x
PE Ratio3 Y	19.79x
PS Forward	3.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.32%
EBITDA Margin	17.83%
FCF margin	14.2%
Gross margin	87.45%
Gross Profit	$1.4B
Gross Profit Growth	6.91%
Gross Profit Growth Q	33.71%
Gross Profit Growth3 Y	14.94%
Gross Profit Growth5 Y	9.4%
Net Income	$152.7M
Net Income Growth	-56.7%
Net Income Growth Years	0%
Pretax Margin	13.06%
Profit Margin	9.78%
Profit Per Employee	$74,498
Profitable Years	3
ROA	4.72
Roa5y	7.01
ROCE	6.54
ROE	9.36
Roe5y	18.55
ROIC	8.69
Roic5y	24.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.73%
Cagr15y	6.18%
Cagr1y	15.19%
Cagr20y	2.51%
Cagr3y	6.48%
Cagr5y	10.08%
EPS Growth	-56.49
EPS Growth Years	0
FCF Growth	-53.94%
FCF Growth5 Y	36.06%
OCF Growth	-50.43%
OCF Growth5 Y	26.86%
Revenue Growth	3.21x
Revenue Growth Q	28.19x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	11.71x
Revenue Growth5 Y	8.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.49
Assets	$4.3B
Cash	$511.9M
Current Assets	$1.4B
Current Liabilities	$599.5M
Debt	$1.6B
Debt EBITDA	$5.42
Debt Equity	$0.9
Debt FCF	$7.13
Equity	$1.8B
Interest Coverage	7.22
Liabilities	$2.5B
Long Term Assets	$2.9B
Long Term Liabilities	$1.9B
Net Cash	$-1.1B
Net Cash By Market Cap	$-18.34
Net Debt EBITDA	$3.84
Net Debt Equity	$0.61
Net Debt FCF	$4.82
Tangible Book Value	$-628.5M
Tangible Book Value Per Share	$-3.78
WACC	4.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.27
Inventory Turnover	0.75
Net Working Capital	$281.4M
Quick ratio	1.53
Working Capital	$759.1M
Working Capital Turnover	$1.74

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.02%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-7.03%
1Y total return	15.17%
200-day SMA	30.37
3Y total return	20.75%
50-day SMA	31.75
50-day SMA vs 200-day SMA	50over200
5Y total return	61.64%
All Time High	98.5
All Time High Change	-64.48%
All Time High Date	2000-03-01
All Time Low	0.94
All Time Low Change	3,632.27%
All Time Low Date	1994-12-19
ATR	1.2
Beta	0.26
Beta1y	0.66
Beta2y	0.8
Ch YTD	25.05
High	35.93
High52	36.6
High52 Date	2026-05-06
High52ch	-4.4%
Low	34.87
Low52	25.17
Low52 Date	2025-09-08
Low52ch	39.04%
Ma50ch	10.2%
Premarket Change Percent	0.51
Premarket Price	$35.58
Price vs 200-day SMA	15.23%
RSI	57.71
RSI Monthly	58.03
RSI Weekly	61.2
Sharpe ratio	0.45x
Sortino ratio	0.86
Total Return	0.02%
Tr YTD	25.05
Tr15y	145.75%
Tr1m	5.97%
Tr1w	4.82%
Tr3m	0.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	13
Analyst Count Top	10
Analyst Price Target Top	$44.8
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.15
Earnings Revenue Estimate	360,869,400x
Earnings Revenue Estimate Growth	17.73x
Operating Income	$239.4M
Operating Income Growth	-38.79
Operating Income Growth3 Y	192.9
Operating margin	15.32
Price target	$44.62
Price Target Change	$27.52
Price Target Change Top	$28.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	154,105,601%
Float Percent	92.46%
Net Borrowing	1,511,557,000
Shares Insiders	1.49%
Shares Institutions	103.58%
Shares Out	166,675,807
Shares Qo Q	-1.97%
Shares Yo Y	-0.02%
Short Float	12.77%
Short Ratio	6.81
Short Shares	11.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$109.6M
Average Volume	1,822,139.6x
Bv Per Share	10.52
CAPEX	$-34.4M
Ch10y	-8.52
Ch15y	141.8
Ch1m	5.97
Ch1w	4.82
Ch1y	15.17
Ch20y	61.54
Ch3m	0.23
Ch3y	18.81
Ch5y	59.05
Ch6m	6.39
Change	-1.16%
Change From Open	-2.18
Close	35.4
Days Gap	1.05
Depreciation Amortization	39,173,000
Dollar Volume	90,856,083.7
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$239.4M
EBITDA	$278.6M
EPS	$0.91
F Score	5
FCF	$221.8M
FCF EV Yield	3.21x
FCF Per Share	$1.33
Financing CF	1,486,151,000
Fiscal Year End	December
Founded	1,987
Goodwill	596,029,000
Graham Number	14.67355
Graham Upside	-58.06
Income Tax	$51.3M
Investing CF	-1,790,605,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2000-05-15
Last Split Type	Forward
Last10k Filing Date	2026-02-25
Ma150	31.13
Ma150ch	12.39%
Ma20	34.13
Ma20ch	2.51%
Net CF	-48,255,000
Next Earnings Date	2026-07-28
Open	35.77
Optionable	Yes
P FCF Ratio	26.29
P OCF Ratio	22.76
Position In Range	11.32
Ppne	298,835,000
Pre Close	35.4
Price Date	2026-05-08
Price EBITDA	$20.93
Relative Volume	1.43x
Revenue	1,562,300,000x
SBC By Revenue	7.18x
Share Based Comp	112,236,000
Tax By Revenue	3.28x
Tax Rate	25.15%
Tr20y	64.17%
Tr6m	6.39%
Volume	2,596,630
Z Score	1.68

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ALKS pay a dividend?

Capital-return profile for this ticker.

Performance

ALKS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ALKS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+103.6%

Float: +92.5% of shares outstanding

Insider ownership

+1.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ALKS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.7

Neutral momentum band

Price vs 200-day MA

+15.2%

50/200-day relationship not available

Beta (5Y)

0.26

Less volatile than the market

Sharpe ratio

0.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ALKS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ALKS stock rating?

Alkermes plc is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ALKS analysis?

The full report lives at /stocks/ALKS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ALKS?

The latest report frames ALKS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ALKS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.